Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.
Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Hatta Y, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Ishigatsubo Y, Takeuchi K. Tomita N, et al. Among authors: yamamoto w, yamamoto m. Cancer Sci. 2012 Feb;103(2):245-51. doi: 10.1111/j.1349-7006.2011.02139.x. Epub 2011 Nov 29. Cancer Sci. 2012. PMID: 22044593 Free article.
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Takahashi H, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Nakajima H, Miura I, Takeuchi K. Tomita N, et al. Among authors: yamamoto w, yamamoto m. Leuk Lymphoma. 2018 Jan;59(1):97-104. doi: 10.1080/10428194.2017.1330541. Epub 2017 Jun 8. Leuk Lymphoma. 2018. PMID: 28593796
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial.
Nakamae H, Yamamoto M, Sakaida E, Kanda Y, Ohmine K, Ono T, Matsumura I, Ishikawa M, Aoki M, Maki A, Shibayama H. Nakamae H, et al. Among authors: yamamoto m. Int J Hematol. 2022 Jan;115(1):33-42. doi: 10.1007/s12185-021-03216-5. Epub 2021 Sep 11. Int J Hematol. 2022. PMID: 34508295 Clinical Trial.
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Tanaka K, Ichikawa A, Umezawa N, Yamamoto K, Yoshifuji K, Okada K, Nogami A, Umezawa Y, Nagao T, Sakashita C, Mori T, Tohda S, Koike R, Yasuda S, Yamamoto M. Tanaka K, et al. Among authors: yamamoto m, yamamoto k. Cancer Sci. 2023 Sep;114(9):3719-3727. doi: 10.1111/cas.15894. Epub 2023 Jun 26. Cancer Sci. 2023. PMID: 37365854 Free PMC article.
Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N, Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, Kanda Y, Okamoto S, Sunami K, Takamatsu H. Ikeda T, et al. Among authors: yamamoto m. Hematol Oncol. 2019 Dec;37(5):586-594. doi: 10.1002/hon.2688. Epub 2019 Nov 23. Hematol Oncol. 2019. PMID: 31674032
13,380 results
You have reached the last available page of results. Please see the User Guide for more information.